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According to cross-sectional studies, oxygen saturation is elevated in retinal vessels in dia-
betic patients. We evaluated how retinal oxygenation (metabolic marker), vessel diameters
and retinopathy grade (structural markers) change over time in diabetic patients.
Design
Prospective cohort study following screening in a hospital setting.
Methods
Retinal oximetry images were acquired in 214 patients with the Oxymap T1 oximeter. Imag-
ing was repeated after a median of 3.0 years (range 0.76–6.8 years). Oxygen saturation
and vessel diameters were measured in the right eye. Semiquantitative grading of retinopa-
thy according to international guidelines and red lesion count were performed on fundus
photographs.
Results
Retinopathy grade according to the international semiquantitative grading system was
unchanged. Arteriolar saturation increased by 0.75±0.15 percentage points per year of fol-
low-up (p<0.0001). Venular saturation increased by 1.74±0.26 percentage points per year
(p<0.0001) and arteriovenous difference decreased by 0.99±0.20 percentage points per
year (p<0.0001). Arteriolar diameters decreased by 2.7±8.5μm (p<0.0001) between visits
and venular diameters decreased by 2.4±9.1μm (p = 0.0002). Median increase in red lesion
count between visits was 2 lesions (range -128 to 212 lesions, p<0.0001). The change in
red lesion count and change in diameters did not correlate with the length of follow-up
(p>0.44).
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Conclusions
Oxygen saturation in larger retinal vessels can increase and arteriovenous difference can
decrease over time in diabetic patients without any observable changes in retinopathy
grade. The results suggest that changes in retinal oxygen saturation may precede progres-
sion of diabetic retinopathy or that oxygen saturation is more sensitive to disease progres-
sion than retinopathy grade.
Introduction
Diabetic retinopathy is diagnosed on the basis of morphological lesions in the retina related
to disturbances in retinal blood flow, such as haemorrhages, microaneurysms, exudates, in-
traretinal microvascular abnormalities and neovascularizations [1, 2]. The new vessels develop
secondary to capillary occlusion in the retinal periphery [3]. Hypoxia, which results from
capillary occlusions, is assumed to stimulate the release of growth factors that initate the for-
mation of new vessels to result in proliferative diabetic retinopathy [4]. The occlusion of retinal
capillaries also stimulates the formation of shunt vessels to bypass the occluded retinal areas
[5, 6].
It would be desirable to monitor diabetic retinopathy with parameters that reflect the early
metabolic or ischemic stages of the disease rather than the consequent morphological changes.
Monitoring metabolic changes, which are likely to occur early, may provide an opportunity
for more timely management of the disease. Such a parameter might be the oxygen saturation
in the larger retinal vessels that can be measured by dual wavelength retinal oximetry [7, 8].
Using this technique, the bypassing of the retinal capillary bed in diabetic retinopathy has been
confirmed by an increased oxygen saturation in intraretinal shunts [6] and neovascularizations
[9]. The resulting increase in oxygen saturation in retinal venules has been documented in a
number of studies [10–21] although one study found a trend towards a decrease [22].
The evidence that oxygen saturation in larger retinal vessels increases with increasing sever-
ity of retinopathy is based on cross-sectional studies. In order to elucidate the clinical potential
of retinal oximetry there is a need for prospective studies to document whether changes in reti-
nal oxygen saturation precede or follow the development of the morphological lesions in the
disease.
Therefore, changes in oxygen saturation over time were observed in a cohort of diabetic
patients from which baseline data have previously been reported [14]. The possible correlation
between changes in oxygen saturation in larger retinal vessels and changes in vessel diameters
or the severity of retinopathy was tested.
Methods
Patients
All patients had given their written informed consent to participate in the examination pro-
gramme and the collection of data for the project was approved by the local medical ethics
committee.
The baseline examination had been performed on 722 consecutive patients examined at the
Department of Ophthalmology, Aarhus University Hospital. The patients had been referred to
the department from private ophthalmologists or the regional screening clinic for diabetic reti-
nopathy for specialist evaluation of diabetic retinopathy. The clinical examination included
fundus photography and retinal oximetry and is described in detail in [14]. In 294 of these
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patients, the examination resulted in treatment of diabetic retinopathy and these patients were
excluded from the study. In the remaining 428 patients, repeated oximetry was planned for
subsequent follow-up examinations. Among these, 216 patients had died or had been referred
for follow-up with a private practitioning ophthalmologist. Therefore, follow-up examinations
that included oximetry were performed in 214 patients after a median time of 3.0 years (range
0.76 to 6.8 years). The background data of these patients at baseline are shown in Table 1.
Retinal oximetry
Retinal oximetry images were acquired with the Oxymap T1 retinal oximeter (Oxymap ehf.,
Reykjavik, Iceland). The right eye of each patient was measured. The oximeter has been
described previously [23]. It is based on a Topcon TRC-50DX fundus camera (Topcon Corpo-
ration, Tokyo, Japan). Beam splitting optics, narrow band-pass light filters and two digital
cameras (Insight IN1800, Diagnostic Instruments Inc., Sterling Heights MI) are added to the
top port of the fundus camera. The oximeter captures two images of the retina simultaneously
at different wavelengths. One image is captured at 570nm and is insensitive to oxygen satura-
tion and another image is captured at 600nm and is sensitive to saturation. The Oxymap Ana-
lyzer software finds retinal vessels in the image and estimates their light absorbance at both
wavelengths. The light absorbance values are then used to estimate oxygen saturation in the
retinal vessels.
Data analysis
Retinopathy grade. The severity of retinopathy was graded on a semiquantitative scale
with five steps ranging from no retinopathy to treatment requiring retinopathy according to
international guidelines [1, 24]. The distribution of patients with different retinopathy grades
on this scale was unbalanced, with all patients belonging to category 0, 1 and 2 [1]. Therefore
retinopathy was also graded in more detail by an experienced grader who, blinded to the result
of the oximetry, counted the number of red lesions (haemorrhages and/or microaneurysms)
within a fovea-centered 60 degrees fundus photograph. All images were graded by an experi-
enced nurse grader to whom the purpose of the study was unknown. The images were re-eval-
uated by a retinal specialist (TB), who agreed on all the grading levels determined by the nurse
grader. None of the patients had clinically significant macular edema at baseline or follow-up.
Retinal oxygen saturation. At the time of the study, oximetry images from all follow-up
examinations were anonymized and transferred to the University of Iceland, where the analy-
sis was performed masked to grading of patients and other clinical data and the identity of the
patients, using the Oxymap Analyzer software version 2.5.1 (revision 10981).
Oxygen saturation was calculated according to the formula
SatO2 ¼ ða x ODRþ bÞ þ ðc x wþ dÞ;
Table 1. Group characteristics at baseline (mean±standard deviation).
Gender (male / female) 140 / 74
Age 55.3±15.2 years (n = 213)
Type of diabetes (type 1/ type 2) 71 / 143
Duration of diabetes 16.8±11.0 years (n = 213)
Mean arterial blood pressure 103.4±12.6 mmHg (n = 214)
HbA1c 61.4±15.5 mmol/mol (n = 175)
BMI 29.4 ±6.3 (n = 209)
https://doi.org/10.1371/journal.pone.0251607.t001
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where a = -128, b = 124, c = 0.97 and d = -14. ODR is the optical density ratio, calculated from
the images [23] and w is the width of the vessels in pixels.
A measurement area was demarcated with two concentric circles, with diameters of 1.5 and
3.0 disc diameters (see Fig 1). Segments of all retinal arterioles and venules, which had a diam-
eter of 8 pixels (approx. 74 micrometres) or more [25], were measured between these circles.
An average was calculated for all measured retinal arterioles and all measured retinal venules.
The arteriovenous difference was calculated as the difference between those two numbers.
This protocol for retinal oximetry is designed to measure (almost) all blood entering and leav-
ing the retinal circulation. The oximetry results are therefore influenced by both the center
and periphery of the retina.
Image quality score was automatically obtained for all images from the Oxymap Analyzer
software and there was a significant (p = 0.002) reduction in the image quality from the first
visit: mean = 7.7 (range 3.5 to 9.2) to the second visit: mean = 7.4 (range 4.8 to 9.1).
Statistical analysis. The oxygen saturation values were returned to Aarhus and
were merged with the clinical data. Linear regression was used to test the following relation-
ships: (1) The change in oxygen saturation with follow-up time. (2) The change in red lesion
count with follow-up time. (3) The change in oxygen saturation with change in red lesion
count. (4) The change in vessel diameter with follow-up time. (5) The change in oxygen
saturation with change in vessel diameters. (6) The change in red lesion count with change in
diameter. (7) The change in red lesion count with baseline HbA1c values or mean blood
pressure.
Wilcoxon’s signed rank test was used to test if the median change in red lesion count
between visits was different from zero. A t-test was used to test if the change in vessel diameter
between visits was different from zero.
Both mean and median values are given in the results when these differ considerably. For
all statistical analyses, a parametric and non-parametric test were performed in parallel for
completeness. Spearman‘s rank correlation and linear regression were performed on the same
data. Wilcoxon‘s signed rank test or Mann-Whitney test and t-tests were performed on the
Fig 1. An oximetry image. The two blue circles demarcate the measurement area. The inner circle has a diameter of
1.5 disc diameter. The outer circle has a diameter of 3.0 disc diameters. The main retinal vessel segments in this area
are chosen according to a set of detailed rules (Oxymap protocol from November 21st 2013, simple means used).
https://doi.org/10.1371/journal.pone.0251607.g001
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same data. In all but two analyses, the difference in results from a parametric and non-
parametric test was negligible. In those two analyses, results from both tests are given.
Statistical analyses were performed with Graphpad Prism 5.01 (Graphpad Inc., San Diego CA).
Results
Table 2 shows the retinopathy grades according to the International Classification [1] and the
change in retinopathy grade during follow-up.
It can be inferred from Table 2 that retinopathy grade was unchanged in 83% of the
patients, worsened by one grade in 10% and improved by one grade in 7% of the patients. The
number of patients changing category was too low to allow conclusive testing against oximetry
data. Therefore, red lesion count was used as a marker of retinopathy grade.
Fig 2 shows that A) arteriolar and B) venular saturation increased significantly with time of
follow-up. The venular saturation increased more rapidly with time of follow-up, which
implies that C) the arteriovenous difference decreased significantly with time of follow-up.
Inner retinal oxygen extraction fraction, which is arteriovenous difference normalized by arte-
riolar saturation [26], also decreased significantly with time (p<0.0001)
The overall red lesion count increased significantly by a median of 2 lesions, range -128 to
212 lesions (p<0.0001, mean±SD: 15±47 lesions increase). However, Fig 3 shows no correla-
tion between the change in red lesions and time of follow-up. Furthermore, the change in red
lesion count was not correlated with baseline values of the known risk factors HbA1c
(p = 0.59) or mean arterial blood pressure (p = 0.55).
The change in oxygen saturation over time was not correlated with the change in red lesion
count (linear regression, p = 0.83 for arterioles, p = 0.81 for venules and p = 0.63 for arterio-
venous difference).
During the follow-up period, the diameter of retinal arterioles decreased significantly by
0.29±0.91 pixels (approx. 2.7±8.5 micrometers, p<0.0001) and the diameter of retinal venules
decreased by 0.26±0.97 pixels (approx. 2.4±9.1 micrometers, p = 0.0002, median change = 1.30
micrometers). Neither the change in arteriolar nor venular diameter was correlated with the
time of follow-up (linear regression, p = 0.90 and p = 0.98).
The change in diameter was in most cases correlated with change in saturation, see Table 3.
The change in diameter and the change in red lesion count were not correlated (p = 0.29
for arterioles change and p = 0.50 for venules).
Discussion
Diabetic retinopathy is a slowly progressing disease, where it may require years or even
decades to detect morphological progression [27]. Morphological changes are the end result of
Table 2. Retinopathy grades at baseline and change in retinopathy grade during follow-up.
Baseline Number of patients
Grade 0 (no retinopathy) 24
Grade 1 (mild non-proliferative retinopathy) 54
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Fig 2. The change in oxygen saturation. Change from baseline to follow-up visit, plotted against the time of follow-
up. Each point denotes one patient (n = 214). A. Saturation in retinal arterioles increased by 0.75 percent per year of
follow-up (p<0.0001). B. Saturation in retinal venules increased by 1.74 percent per year of follow-up (p<0.0001). C.
The arteriovenous difference in saturation decreased by 0.99 percent per year of follow-up (p<0.0001).
https://doi.org/10.1371/journal.pone.0251607.g002
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a chain of events that starts with metabolic dysregulation. The International classification of
diabetic retinopathy is based on a semiquantitative scale that has few grades that precludes a
detailed assessment of disease progression. Therefore, long follow-up periods are needed in
order to study natural history or effects of interventions on the disease. The present study was
conducted on patients referred to a secondary care center who had a higher risk for progres-
sion than the general population of diabetic patients. Therefore, it was considered relevant to
study changes in oxygen saturation and retinopathy grade over a median follow-up time of 3
years [28, 29]. Nevertheless, there was little progression, which is likely due to the intensive
control by endocrinologists for these patients and due to exclusion of patients who received
ocular treatment between visits [30, 31]. Some patients had a very short follow-up time and
others had longer. This variable follow-up time allowed us to test whether changes in oximetry
values or structural parameters are correlated with length of follow-up.
Our results showed no clear progression of retinopathy, as defined by the International
Classification [1]. Progression may have occurred within grades and could perhaps have been
detected with more detailed measurements, such as OCTA. However, the standard grading is
coarse and may, in many cases, have too little sensitivity to detect progression during this rela-
tively short follow-up time. We therefore resorted to more detailed analysis of red lesion count
for measuring morphological progression. We found a small overall increase in the red lesion
count between visits but this was not related to the time of follow-up and there was a quite
large variability in this parameter. This may be a consequence of fluctuations due to the fact
Fig 3. The change in red lesion count. Plotted as a function of follow-up time. There was no significant change in red
lesions with time.
https://doi.org/10.1371/journal.pone.0251607.g003
Table 3. Linear regression between the change in saturation (ΔSatO2) between visits and change in diameter (ΔDiameter).
R2 P value for slope
ΔSatO2(arterioles) = 0.83�ΔDiameter(arterioles)+1.96 0.037 0.0047
ΔSatO2(arterioles) = 0.99�ΔDiameter(venules)+1.98 0.061 0.0003
ΔSatO2(venules) = 1.69�ΔDiameter(arterioles)+4.49 0.050 0.0010
ΔSatO2(venules) = 1.05�ΔDiameter(venules)+4.27 0.022 0.028
a
ΔSatO2(AV) = -0.86�ΔDiameter(arterioles)-2.53 0.022 0.028
b
ΔSatO2(AV) = -0.06�ΔDiameter(venules)-2.30 0.00014 0.86
ap = 0.11 for non-parametric analysis.
bp = 0.13 for non-parametric analysis.
https://doi.org/10.1371/journal.pone.0251607.t003
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that a change in red lesion count reflects the balance between formation and resorption of
lesions [32]. Altogether, the results indicate that with the present patient material a longer fol-
low-up time is needed in order to identify changes in retinopathy grade.
Another structural parameter that we measured was the diameter of retinal vessels. There
was a slight decrease in diameter of arterioles and venules between visits, which was significant
for the group as a whole.
Oxygen saturation, however, clearly increased with length of follow-up in both arterioles
and venules. The changes in saturation with time may reflect underlying metabolic progres-
sion of the disease that may later manifest more clearly in morphological progression of dia-
betic retinopathy. This will be tested with longer follow-up. It must be kept in mind, that most
patients had retinopathy at baseline and it remains to be seen whether a change in oxygen satu-
ration precedes the initiation of diabetic retinopathy.
Increased saturation in retinal arterioles has been observed in several cross-sectional studies
[11, 12, 14–16, 18–21]. Various explanations have been proposed for this phenomenon, such
as thickening of vessel walls and reduced counter-current exchange of oxygen between arteri-
oles and nearby venules. Previous papers have also mentioned the possibility of faster retinal
blood flow in diabetic patients, which would allow less oxygen to escape from per unit volume
of blood through the walls of retinal arterioles [33]. The saturation increased more rapidly
with follow-up in venules than in arterioles and the arteriovenous difference therefore
decreased with follow-up. This result is in agreement with some of the cross-sectional oximetry
studies [10, 12, 16, 17, 19], while other studies have not found such a decrease in the arteriove-
nous saturation difference [11, 18, 21]. A recent study showed that the linear velocity of the
blood is inversely related to the measured oxygen saturation [34], and according to this, a
decrease in this velocity might also contribute to the measurement of increased oxygen satura-
tion in the larger retinal vessels. This would be in accordance with a gradual occlusion of the
capillary bed in the periphery that is a prominent finding in the development of diabetic reti-
nopathy [3, 35].
The inverse relation between linear velocity and measured oxygen saturation can be mea-
sured in both arterioles and venules and therefore the arteriovenous difference may be a more
reliable parameter for oxygen saturations than arteriolar or venular saturation alone. A
decreased arteriovenous difference in oxygen saturation may be a sign of poor delivery of oxy-
gen by the retinal capillaries. This may be due to increased capillary occlusion and shunting to
bypass the occluded vascular bed during the follow-up. A recent study has suggested that the
arteriovenous difference may potentially be used as a measure of the extent of capillary occlu-
sion [6]. This would imply that retinal oximetry could be used to quantify retinal changes that
otherwise require invasive procedures such as fluorescein angiography or photographic tech-
niques designed to capture images outside the central retina. This might point to a potential
role of retinal oximetry for routine follow-up of diabetic patients.
The current study is the first longitudinal retinal oximetry study on diabetic retinopathy,
apart from studies that included short-term follow-up to test the effect of treatment [13, 36–
38]. Our previous cross-sectional study suggested that there is a relationship between oxygen
saturation and severity of diabetic retinopathy [14]. However, oximetry and a combination of
conventional risk factors were only able to explain 10 to 14% of the variability of the severity in
that cross-sectional study. This may be due to the fact that diabetic retinopathy develops over a
long time and measurements at a single point in time may not reflect the situation in the past
years and decades, during which the disease has developed. In the current study, changes in
red lesion count were quite variable between patients and not related to the time of follow-up.
This may be due to fluctuations in risk factors, such as blood glucose and blood pressure or
simply because clear structural changes take longer time to develop. Another factor that may
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influence the results is the selection of patients. The selection process may mean that the stud-
ied sample is not entirely representative of progression of diabetic retinopathy in general.
About two thirds of the patients were males and about two thirds of the group had type 2 dia-
betes. Most of the patients were of Caucasian origin. Importantly, we chose to exclude patients,
who received ocular treatment between visits. This was done to isolate the effect of the disease
progression, without confounding effects of different treatment. This probably also means that
our selected patients had less progression than the study population as a whole.
The main strengths of retinal oximetry are its non-invasive nature and the ability to gauge
metabolism. There are also limitations, which include possible effects of image quality on
results and a relatively small size of change in individual patients. It is most likely that retinal
oximetry can be used with other parameters, rather than as a standalone measurement. The
same is true for almost every parameter in management of diabetes and diabetic retinopathy.
In conclusion, in a prospective study we have found progressive changes in retinal oxygen
saturation in diabetic patients during a time interval of 3 years while no changes were detected
on the conventional semiquantitative grading scale for diabetic retinopathy. This suggests that
retinal oximetry is a sensitive measure of progression of the disease. While it may be assumed
that diabetic retinopathy progresses over time, longer follow-up studies in cohorts where reti-
nopathy grading actually increases are needed in order to confirm that the observed changes
in oxygen saturation are followed by progression of retinopathy.
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